Public consultation feedback and subsequent changes to the Criteria

The Specialist Working Groups for Haematology, Immunology (with Dermatology and Rheumatology input sought as required), Neurology and Transplantation Medicine have considered the feedback and where necessary have revised the medical condition pro forma documents. The documentation was provided to the National Immunoglobulin Governance Advisory Committee (NIGAC) at their meeting on 10 November and they have cleared these for consideration and endorsement by Jurisdictional Blood Committee (JBC) at their meeting in December 2015.

Public consultation feedback

Proposed medical condition pro forma documents  

Established therapeutic role

Emerging therapeutic role

Exceptional circumstances only